Sleep Medicine News

CHARLOTTE, N.C. — Data from a real-world study revealed that treatment with prescription digital therapeutic Somryst achieved reductions in symptoms of insomnia, anxiety and depression, per a late-breaking poster at the SLEEP meeting.

CHARLOTTE, N.C. – Research shows that switching to daylight savings time not only causes short-term daytime sleepiness in adolescents, it may be linked to chronic mental health issues, Christina F. Chick, PhD, said at the SLEEP meeting.

CHARLOTTE, N.C. — Deviation from typical sleep pattern was found to affect daily metacognition in college students, according to a poster presented at the SLEEP meeting.

CHARLOTTE, N.C. — Study participants with a history of migraine experienced less sleep apnea and hypoxia than those without migraine, according to a poster presented at the SLEEP meeting.

Adults who reported taking frequent daily naps had greater risk for essential hypertension and stroke compared with those who never or rarely nap, researchers reported.

A novel, thermally regulated mattress and pillow shortened sleep onset latency and improved sleep quality in a small cohort of healthy individuals, researchers reported in the Journal of Sleep Research.

CHARLOTTE, N.C. – Sharing a bed with a spouse or partner generally led to better sleep and lower levels of depression and anxiety, according to Michael Grandner, PhD, MTR, CBSM, FAASM, at the SLEEP meeting.

The COVID-19 pandemic negatively impacted caregivers and non-caregivers alike, with evidence of increased alcohol consumption and depressive symptoms along with significant sleep disturbances, according to a study published in Alcohol.

The FDA has granted tentative approval to Lumryz, a once-at-bedtime oral treatment for excessive daytime sleepiness or cataplexy in adults with narcolepsy, Avadel Pharmaceuticals announced in a press release.

CHARLOTTE, N.C. — Higher sleep scores were associated with lower mortality hazard, according to a study presented at the SLEEP 2022 meeting.